Home › Funds › TRED AVON FAMILY WEALTH, LLC › ABT
TRED AVON FAMILY WEALTH, LLC position in ABT
ABBOTT LABORATORIES · Health Care
TRED AVON FAMILY WEALTH, LLC reported holding 19,018 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$1.9M, representing 0.57% of its reported portfolio and ranking #32 among its reported holdings. TRED AVON FAMILY WEALTH, LLC has disclosed ABT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-10-20 · Source: SEC EDGAR Form 13F-HR
How TRED AVON FAMILY WEALTH, LLC's ABT position evolved
TRED AVON FAMILY WEALTH, LLC first disclosed a stake in ABT in Q3 2025 at 24,432 shares (US$3.3M). Across 5 filings, TRED AVON FAMILY WEALTH, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 19,018 shares valued at US$1.9M — a reduction of -5,679 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 24.43K | $3.27M | New |
| Q4 2025 | 24.78K | $3.10M | Add |
| Q1 2026 | 24.72K | $2.54M | Hold |
| Q2 2026 | 24.70K | $2.24M | Hold |
| Q3 2026 | 19.02K | $1.88M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABT and 13F data
ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABT
- Vanguard Group 175.56M sh · $22.00B · Q4 2025
- Charles Schwab Investment Management 59.67M sh · $5.41B · Q2 2026
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 59.67M sh · $5.41B · Q2 2026
- Sixth Street Partners Management Company, L.P. 59.67M sh · $5.41B · Q2 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Capital International Investors 34.65M sh · $3.15B · Q2 2026
- Deutsche Bank AG 16.71M sh · $1.52B · Q2 2026
More on TRED AVON FAMILY WEALTH, LLC
FAQ
How long has TRED AVON FAMILY WEALTH, LLC held ABT?
TRED AVON FAMILY WEALTH, LLC has disclosed ABT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is TRED AVON FAMILY WEALTH, LLC's current position in ABT?
As of Q3 2026, TRED AVON FAMILY WEALTH, LLC holds 19.02K shares of ABT (ABBOTT LABORATORIES), valued at $1.88M, representing 0.57% of its reported portfolio and ranking #32.
Has TRED AVON FAMILY WEALTH, LLC been buying or selling ABT?
In the latest 13F filing (Q3 2026), TRED AVON FAMILY WEALTH, LLC reduced its position in ABT.
Which other funds hold ABT?
Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.